NO20000262D0 - Plasmider, deres konstruksjon og deres anvendelse i fremstilling av interleukin-4 og interleukin-4-muteiner - Google Patents
Plasmider, deres konstruksjon og deres anvendelse i fremstilling av interleukin-4 og interleukin-4-muteinerInfo
- Publication number
- NO20000262D0 NO20000262D0 NO20000262A NO20000262A NO20000262D0 NO 20000262 D0 NO20000262 D0 NO 20000262D0 NO 20000262 A NO20000262 A NO 20000262A NO 20000262 A NO20000262 A NO 20000262A NO 20000262 D0 NO20000262 D0 NO 20000262D0
- Authority
- NO
- Norway
- Prior art keywords
- interleukin
- muteins
- construction
- plasmids
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99100967A EP1022339B1 (en) | 1999-01-20 | 1999-01-20 | Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20000262D0 true NO20000262D0 (no) | 2000-01-19 |
| NO20000262L NO20000262L (no) | 2000-07-21 |
| NO327317B1 NO327317B1 (no) | 2009-06-08 |
Family
ID=8237378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000262A NO327317B1 (no) | 1999-01-20 | 2000-01-19 | Vektor for fremstillingen av IL-4 og IL-4-mutanter, DNA-konstruksjon og E.coli. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6506590B1 (no) |
| EP (1) | EP1022339B1 (no) |
| JP (2) | JP2000210091A (no) |
| KR (1) | KR100665148B1 (no) |
| AT (1) | ATE334202T1 (no) |
| AU (1) | AU772897B2 (no) |
| CA (1) | CA2294575C (no) |
| CZ (1) | CZ294279B6 (no) |
| DE (1) | DE69929638T2 (no) |
| DK (1) | DK1022337T3 (no) |
| ES (1) | ES2269027T3 (no) |
| HU (1) | HU224491B1 (no) |
| NO (1) | NO327317B1 (no) |
| PT (1) | PT1022337E (no) |
| SK (1) | SK285603B6 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10022258A1 (de) | 2000-05-08 | 2001-11-15 | Bayer Ag | Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration |
| KR100443570B1 (ko) * | 2001-07-31 | 2004-08-09 | 크레아젠 주식회사 | 재조합 인간 인터루킨-4의 제조방법 |
| EP1314739A1 (en) | 2001-11-22 | 2003-05-28 | Bayer Ag | Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines |
| JP2006055082A (ja) * | 2004-08-20 | 2006-03-02 | National Institute Of Advanced Industrial & Technology | 発光甲虫由来赤色発光酵素安定体の生産及び精製法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4689406A (en) * | 1983-08-10 | 1987-08-25 | Amgen | Enhancement of microbial expression of polypeptides |
| AU597951B2 (en) * | 1986-03-27 | 1990-06-14 | Monsanto Company | Enhanced protein production in bacteria by employing a novel ribosome binding site |
| ATE123526T1 (de) * | 1987-08-17 | 1995-06-15 | Hoffmann La Roche | Hochreprimierbare expressionskontrollsequenzen. |
| FR2724665B1 (fr) * | 1994-09-16 | 1996-12-20 | Rhone Poulenc Rorer Sa | Procede de production de proteines recombinantes, plasmides et cellules modifiees |
| MY124565A (en) * | 1996-07-19 | 2006-06-30 | Bayer Corp | High-affinity interleukin-4-muteins |
-
1999
- 1999-01-20 EP EP99100967A patent/EP1022339B1/en not_active Expired - Lifetime
- 1999-01-20 DE DE69929638T patent/DE69929638T2/de not_active Expired - Lifetime
-
2000
- 2000-01-07 AT AT00100129T patent/ATE334202T1/de active
- 2000-01-07 DK DK00100129T patent/DK1022337T3/da active
- 2000-01-07 ES ES00100129T patent/ES2269027T3/es not_active Expired - Lifetime
- 2000-01-07 PT PT00100129T patent/PT1022337E/pt unknown
- 2000-01-14 JP JP2000006477A patent/JP2000210091A/ja active Pending
- 2000-01-14 US US09/483,419 patent/US6506590B1/en not_active Expired - Fee Related
- 2000-01-17 CA CA002294575A patent/CA2294575C/en not_active Expired - Fee Related
- 2000-01-19 KR KR1020000002310A patent/KR100665148B1/ko not_active IP Right Cessation
- 2000-01-19 CZ CZ2000214A patent/CZ294279B6/cs not_active IP Right Cessation
- 2000-01-19 NO NO20000262A patent/NO327317B1/no not_active IP Right Cessation
- 2000-01-19 SK SK76-2000A patent/SK285603B6/sk unknown
- 2000-01-20 AU AU12507/00A patent/AU772897B2/en not_active Ceased
- 2000-01-20 HU HU0000185A patent/HU224491B1/hu not_active IP Right Cessation
-
2010
- 2010-08-27 JP JP2010190917A patent/JP2010284174A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| HU224491B1 (hu) | 2005-09-28 |
| DK1022337T3 (da) | 2006-11-06 |
| AU772897B2 (en) | 2004-05-13 |
| ATE334202T1 (de) | 2006-08-15 |
| DE69929638T2 (de) | 2006-09-21 |
| CA2294575C (en) | 2009-04-07 |
| SK762000A3 (en) | 2000-08-14 |
| HU0000185D0 (en) | 2000-04-28 |
| EP1022339B1 (en) | 2006-02-01 |
| PT1022337E (pt) | 2006-11-30 |
| HUP0000185A2 (en) | 2002-09-28 |
| KR20000053523A (ko) | 2000-08-25 |
| KR100665148B1 (ko) | 2007-01-09 |
| DE69929638D1 (de) | 2006-04-13 |
| CZ2000214A3 (cs) | 2000-08-16 |
| NO327317B1 (no) | 2009-06-08 |
| JP2000210091A (ja) | 2000-08-02 |
| CA2294575A1 (en) | 2000-07-20 |
| CZ294279B6 (cs) | 2004-11-10 |
| EP1022339A1 (en) | 2000-07-26 |
| ES2269027T3 (es) | 2007-04-01 |
| US6506590B1 (en) | 2003-01-14 |
| AU1250700A (en) | 2000-07-27 |
| NO20000262L (no) | 2000-07-21 |
| JP2010284174A (ja) | 2010-12-24 |
| SK285603B6 (sk) | 2007-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE405647T1 (de) | Rekombinantes gelatin in impstoffen | |
| DK1021547T3 (da) | Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf | |
| DK1270565T3 (da) | 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater | |
| DK1009832T3 (da) | Cytokin betegnet LERK-6 | |
| DK371389D0 (da) | Substituerede aminomethyltetraliner og deres heterocycliske analoge, deres fremstilling og anvendelse | |
| DE60228120D1 (de) | Sauerstoffionenleitendes keramikmaterial und verwendung davon | |
| ATE231869T1 (de) | Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung | |
| TR199901772T2 (no) | ||
| DE60208044D1 (de) | Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung | |
| DK0886679T3 (da) | Parakoppevira indeholdende fremmed DNA, fremstilling heraf og deres anvendelse i vacciner | |
| NO971503L (no) | Kolkisinderivater og deres terapeutiske anvendelse | |
| DE60228764D1 (de) | R-bambuterol, seine herstellung und therapeutische verwendungen | |
| NO20000262D0 (no) | Plasmider, deres konstruksjon og deres anvendelse i fremstilling av interleukin-4 og interleukin-4-muteiner | |
| NO20001934L (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
| ATE341339T1 (de) | Zusammensetzungen von rekombinanten papillomavirus vakzinen | |
| FR2804320B1 (fr) | Composition cosmetique favorisant la respiration cellulaire | |
| EP1808179A3 (en) | Use of HSP20 for promoting wound healing and/or reducing scar formation | |
| DK575787D0 (da) | Rekombinant hcmv-afledt plasmid, dets fremstilling og anvendelse | |
| EP1022337A3 (en) | Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins | |
| NO20023015L (no) | Humant heparanasebeslektet polypeptid og nukleinsyre | |
| EE200300535A (et) | 4-(fenüül(piperidiin-4-üül)amino)bensamiidi derivaadid ja nende kasutamine valu, ärevuse või seedetrakti häirete raviks | |
| DE60216321D1 (de) | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazinoä4,5-büindol-1-karboxamid-derivate, ihre herstellung und therapeutische verwendung | |
| DE50214446D1 (de) | Neue verwendung von lungensurfactant | |
| NO910331D0 (no) | Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. | |
| TR200000916T2 (tr) | İkameli piperidin türevleri. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |